Orchestra BioMed Holdings, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Orchestra BioMed Holdings, Inc. (OBIO) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $561.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-12
- Orchestra BioMed Holdings, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $561.00K, a 64.52% increase from fiscal 2024.
- Orchestra BioMed Holdings, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $341.00K, a 22.85% decline from fiscal 2023.
- Orchestra BioMed Holdings, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $442.00K, a 117.73% increase from fiscal 2022.
- Orchestra BioMed Holdings, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $203.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $561.00K 10-K · filed 2026-03-12 |
| 2024-12-31 | $341.00K 10-K · filed 2026-03-12 |
| 2023-12-31 | $442.00K 10-K · filed 2025-03-31 |
| 2022-12-31 | $203.00K 10-K · filed 2024-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |